Home » UK Marketing Authorization Changes Must Follow EU Regulations
UK Marketing Authorization Changes Must Follow EU Regulations
January 14, 2010
The UK’s Medicines and Healthcare Regulatory products Agency (MHRA) says that all variations to marketing authorizations (MAs) must be approved according
to new EU regulations, even if the variations apply only to products in the UK.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor